Psychiatria pre prax 4/2017
Current and potential pharmaceutical possibilities in PTSD treatment
Posttraumatic stress disorder (PTSD) is a prolonged or delayed response of an individual to life-threatening situations. The disease often has a chronic progression and negatively affects the quality of the patients’ life. The article offers a review of currently used psychopharmaceuticals as well as potentially potent pharmaceuticals, which has not been recommended in clinical practice so far. Psychotherapeutic approaches that form an integral part of PTSD therapy go beyond the overview and attention to them will be paid elsewhere.
Keywords: PTSD, treatment, antidepressants, mood stabilizers, antipsychotics, propranolol, hydrocortisone, MDMA, D-cycloserine, alpha 2 Adrenergic Receptor Agonists
